Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group. [electronic resource]
Producer: 20031210Description: 4207-13 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Aged, 80 and over
- Amifostine -- therapeutic use
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms -- drug therapy
- Cisplatin -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Middle Aged
- Neurologic Examination
- Paclitaxel -- administration & dosage
- Peripheral Nervous System Diseases -- chemically induced
- Radiation-Protective Agents -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.